Treatment of hepatitis C virus genotype 4 with peginterferon alfa-2a: Impact of bilharziasis and fibrosis stage

Tarih
2006
Yazar
AL-MARRI, A.
Bener, Abdulbari
MORAD, N.
YAKOOB, R.
AMER, A. M.
DERBALA, M. F.
AL KAABI, S. R.
EL DWEIK, N. Z.
PASIC, F.
BUTT, M. T.
Üst veri
Tüm öğe kaydını göster
Özet
AIM: To evaluate pegylated interferon alpha2a (PegIFN-alpha 2a) in Egyptian patients with HCV genotype 4, and the impact of pretreatment viral load, co-existent bilharziasis and histological liver changes on response rate.
Bağlantı
http://hdl.handle.net/20.500.12627/44820
https://doi.org/10.3748/wjg.v12.i35.5692
Koleksiyonlar